Literature DB >> 7408410

Relationship between concentration and anticoagulant effect of heparin in plasma of normal subjects: magnitude and predictability of interindividual differences.

L R Whitfield, G Levy.   

Abstract

The purposes of this investigation were to determine the magnitude of inter- and intraindividual variations in the relationship between heparin concentration and anticoagulant effect in normal adults, and to determine whether these variations are asociated with, and therefore predictable from, certain physiologic characteristics of individual subjects. Citrated plasma was obtained from 12 men and 5 women, 21 to 35 yr old. Heparin was added to the plasma to yield concentrations of 0.05 to 1.0 U/ml and the activated partial thromboplastin time (APTT) was determined. These studies were repeated once or twice over 65 days. Baseline APTT values (i.e., ATPP without added heparin) ranged from 25.6 to 36.2 sec and the hematocrit ranged from 39% to 50%. Both measures showed little intrasubject variation on the same day or on different days. There was an excellent linear relationship between In APTT and heparin concentration in the 0.05- to 0.8-U/ml range (r2 > 0.987 in all cases). The slope value for this relationship ranged from 1.51 to 3.88 ml/U and these interindividual differences were well reproducible on repeated testing. Women had lower hematocrits (p < 0.05) and higher slope values (p < 0.01) than men. Multiple linear regression analysis revealed a linear relationship between observed slope values and slope values calculated as a function of both hematocrit and baseline APTT. Age, weight, and the concentrations of various plasma proteins did not contribute significantly to the predictability of the slope. A multiple linear regression equation with hematocrit and baseline APtt as independent variables yielded a multiple correlation coefficient of 0.875 (p < 0.01). Thus, it may be possible to predict the APTT value produced by a given concentration of heparin in an individual subject from the subject's baseline APTT and hematocrit.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7408410     DOI: 10.1038/clpt.1980.195

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  11 in total

Review 1.  The hemostatic defect of cardiopulmonary bypass.

Authors:  Matthew Dean Linden
Journal:  J Thromb Thrombolysis       Date:  2003-12       Impact factor: 2.300

2.  Perspectives on the history and scientific contributions of Gerhard Levy.

Authors:  Ho-Leung Fung; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-09-24       Impact factor: 2.745

3.  Gender differences in the pharmacodynamics of barbiturates in rats.

Authors:  A Hoffman; G Levy
Journal:  Pharm Res       Date:  1989-11       Impact factor: 4.200

4.  Pharmacodynamic modeling of digoxin-induced bradycardia.

Authors:  S J Vetticaden; W H Barr; T B Allison
Journal:  J Pharmacokinet Biopharm       Date:  1989-02

Review 5.  Predicting effective drug concentrations for individual patients. Determinants of pharmacodynamic variability.

Authors:  G Levy
Journal:  Clin Pharmacokinet       Date:  1998-04       Impact factor: 6.447

6.  Blood transfusion requirements in coronary artery surgery with and without the activated clotting time (ACT) technique.

Authors:  D U Preiss; H Schmidt-Bleibtreu; P Berguson; G Metz
Journal:  Klin Wochenschr       Date:  1985-03-15

7.  Assay-dependent kinetics of heparin: evidence for rapid in vivo activation of heparin.

Authors:  F X McGowan; P V Nash; T D Bjornsson
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

8.  Intersubject variability in the anticoagulant response to heparin in vitro.

Authors:  T D Bjornsson; K M Wolfram
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 9.  Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models.

Authors:  N H Holford; L B Sheiner
Journal:  Clin Pharmacokinet       Date:  1981 Nov-Dec       Impact factor: 6.447

Review 10.  Heparin pharmacokinetics and pharmacodynamics.

Authors:  R J Kandrotas
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.